Patient Assistant Programs for new Hep C Meds

[Guest guest]

Boceprevir (Victrelis) Patient Assistance Program

SUMMARY

Merck has announced programs to help hepatitis C patients obtain its newly

approved HCV protease inhibitor boceprevir.

Telaprevir (Incivek) Patient Assistance Program

SUMMARY

Vertex Pharmaceuticals has started programs to help people with hepatitis C

access its recently approved HCV drug telaprevir.

Caffeine and Liver Disease in People with Hepatitis C

SUMMARY

Regularly consuming larger amounts of caffeine has a significant beneficial

effect on liver inflammation, but not fibrosis, according to biopsy results from

people with chronic hepatitis C.

[Guest guest]

Boceprevir (Victrelis) Patient Assistance Program

SUMMARY

Merck has announced programs to help hepatitis C patients obtain its newly

approved HCV protease inhibitor boceprevir.

Telaprevir (Incivek) Patient Assistance Program

SUMMARY

Vertex Pharmaceuticals has started programs to help people with hepatitis C

access its recently approved HCV drug telaprevir.

Caffeine and Liver Disease in People with Hepatitis C

SUMMARY

Regularly consuming larger amounts of caffeine has a significant beneficial

effect on liver inflammation, but not fibrosis, according to biopsy results from

people with chronic hepatitis C.